Resveratrol inhibits IgE-mediated basophilic mast cell degranulation and passive cutaneous anaphylaxis in mice

Journal of Nutrition

Volumn 143, Issue 5, 2013, Pages 632-639

  Han, Seon Young ^a   Bae, Ji Young ^a   Park, Sin Hye ^a   Kim, Yun Ho ^a   Park, Jung Han Yoon ^a   Kang, Young Hee ^a  

^a Hallym University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; DINITROPHENYL ANTIBODY; HISTAMINE; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN E ANTIBODY; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE C DELTA; PROTEIN KINASE C LAMBDA; PROTEIN KINASE C MU; PROTEIN KINASE C THETA; PROTEIN KINASE C ZETA; PROTEIN KINASE SYK; RESVERATROL;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; ATTENUATION; BASOPHIL DEGRANULATION; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; EAR EDEMA; ENZYME ACTIVATION; HISTAMINE RELEASE; MALE; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PROTEIN PHOSPHORYLATION; RAT;

ANAPHYLAXIS; ANIMALS; ANTIGENS, CD24; BASOPHILS; BETA-N-ACETYLHEXOSAMINIDASES; CHEMOKINE CCL2; CHEMOKINE CXCL2; DIETARY SUPPLEMENTS; DINITROPHENOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; HISTAMINE; HISTAMINE RELEASE; IMMUNOGLOBULIN E; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; PASSIVE CUTANEOUS ANAPHYLAXIS; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; PHYTOTHERAPY; PLANT EXTRACTS; PROTEIN-TYROSINE KINASES; RATS; SERUM ALBUMIN; SKIN; STILBENES; VITIS;

MUS; RATTUS; VITACEAE;

EID: 84876951852     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.112.173302     Document Type: Article

References (32)

1. Jutel M, Akdis CA. Immunological mechanisms of allergen-specific immunotherapy. Allergy. 2011;66:725-732.
2. Kaplan DH, Igyártó BZ, Gaspari AA. Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol. 2012;12: 114-124.
3. Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature. 2008;454:445-454.
4. Schroeder JT. Basophils: emerging roles in the pathogenesis of allergic disease. Immunol Rev. 2011;242:144-160.
5. Gilfillan AM, Beaven MA. Regulation of mast cell responses in health and disease. Crit Rev Immunol. 2011;31:475-529.
6. Shea-Donohue T, Stiltz J, Zhao A, Notari L. Mast cells. Curr Gastroenterol Rep. 2010;12:349-357.
7. Amin K. The role of mast cells in allergic inflammation. Respir Med. 2012;106:9-14.
8. Yokoi H, Choi OH, Hubbard W, Lee HS, Canning BJ, Lee HH, Ryu SD, von Gunten S, Bickel CA, Hudson SA, et al. Inhibition of FcepsilonRIdependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement. J Allergy Clin Immunol. 2008;121:499-505.
9. Aung G, Niyonsaba F, Ushio H, Kajiwara N, Saito H, Ikeda S, Ogawa H, Okumura K. Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines. Immunology. 2011;132:527-539.
10. Yoon E, Beom S, Cheong H, Kim S, Oak M, Cho D, Kim KM. Differential regulation of phospholipase Cgamma subtypes through FcepsilonRI, high affinity IgE receptor. Biochem Biophys Res Commun. 2004;325:117-123.
11. de Castro RO. Regulation and function of syk tyrosine kinase in mast cell signaling and beyond. J Signal Transduct. 2011;2011:507291.
12. Tkaczyk C, Beaven MA, Brachman SM, Metcalfe DD, Gilfillan AM. The phospholipase C gamma 1-dependent pathway of Fc epsilon RI-mediated mast cell activation is regulated independently of phosphatidylinositol 3-kinase. J Biol Chem. 2003;278:48474-48484.
13. Harikumar KB, Aggarwal BB. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle. 2008;7:1020-1035.
14. Švajger U, Jeras M. Anti-inflammatory effects of resveratrol and its potential use in therapy of immune-mediated diseases. Int Rev Immunol. 2012;31:202-222.
15. Baolin L, Inami Y, Tanaka H, Inagaki N, Iinuma M, Nagai H. Resveratrol inhibits the release of mediators from bone marrow-derived mouse mast cells in vitro. Planta Med. 2004;70:305-309.
16. Tominaga T, Kawaguchi K, Kanesaka M, Kawauchi H, Jirillo E, Kumazawa Y. Suppression of type-I allergic responses by oral administration of grape marc fermented with Lactobacillus plantarum. Immunopharmacol Immunotoxicol. 2010;32:593-599.
17. Koo N, Cho D, Kim Y, Choi HJ, Kim KM. Effects of resveratrol on mast cell degranulation and tyrosine phosphorylation of the signaling components of the IgE receptor. Planta Med. 2006;72:659-61.
18. Chung MJ, Kim JM, Lee S, Kim T, Kim D, Baek J, Kim T, Lee J, Kim K, Yoon JA, et al. Suppressive effects of Schizandra chinensis Baillon water extract on allergy-related cytokine generation and degranulation in IgEantigen complex-stimulated RBL-2H3 cells. Nutr Res Pract. 2012;6:97-105.
19. Grant JA, Settle L, Whorton EB, Dupree E. Complement-mediated release of histamine from human basophils. II. Biochemical characterization of the reaction. J Immunol. 1976;117:450-6.
20. Langlois A, Chouinard F, Flamand N, Ferland C, Rola-Pleszczynski M,Laviolette M. Crucial implication of protein kinase C (PKC)-delta, PKC-zeta, ERK-1/2, and p38 MAPK in migration of human asthmatic eosinophils. J Leukoc Biol. 2009;85:656-63.
21. Sada K,Miah SM,Maeno K, Kyo S, Qu X, Yamamura H. Regulation of FceRI-mediated degranulation by an adaptor protein 3BP2 in rat basophilic leukemia RBL-2H3 cells. Blood. 2002;100:2138-44.
22. Min B, Paul WE. Basophils and type 2 immunity. Curr Opin Hematol. 2008;15:59-63.
23. Tan Y, Lim LH. trans-Resveratrol, an extract of red wine, inhibits human eosinophil activation and degranulation. Br J Pharmacol. 2008;155: 995-1004.
24. Oliver JM, Burg DL, Wilson BS, McLaughlin JL, Geahlen RL. Inhibition of mast cell Fc epsilon R1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol. J Biol Chem. 1994; 269:29697-703.
25. Miura K, Lavens-Phillips S, MacGlashan DW Jr. Piceatannol is an effective inhibitor of IgE-mediated secretion from human basophils but is neither selective for this receptor nor acts on syk kinase at concentrations where mediator release inhibition occurs. Clin Exp Allergy. 2001;31:1732-9.
26. Guler R, Afshar M, Arendse B, Parihar SP, Revaz-Breton M, Leitges M, Schwegmann A, Brombacher F. PKCd regulates IL-12p40/p70 production by macrophages and dendritic cells, driving a type 1 healer phenotype in cutaneous leishmaniasis. Eur J Immunol. 2011;41:706-15.
27. Lusková P, Dráber P. Modulation of the Fcepsilon receptor I signaling by tyrosine kinase inhibitors: search for therapeutic targets of inflammatory and allergy diseases. Curr Pharm Des. 2004;10:1727-37.
28. Nakano N, Nishiyama C, Tokura T, Nagasako-Akazome Y, Ohtake Y, Okumura K, Ogawa H. Procyanidin C1 from apple extracts inhibits Fc epsilon RI-mediated mast cell activation. Int Arch Allergy Immunol. 2008;147:213-21.
29. Qin HD, Shi YQ, Liu ZH, Li ZG, Wang HS, Wang H, Liu ZP. Effect of chlorogenic acid on mast cell-dependent anaphylactic reaction. Int Immunopharmacol. 2010;10:1135-41.
30. Kempuraj D, Madhappan B, Christodoulou S, Boucher W, Cao J, Papadopoulou N, Cetrulo CL, Theoharides TC. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br J Pharmacol. 2005;145:934-44.
31. Kim JW, Lee JH, Hwang BY, Mun SH, Ko NY, Kim do K, Kim B, Kim HS, Kim YM, Choi WS. Morin inhibits Fyn kinase in mast cells and IgEmediated type I hypersensitivity response in vivo. Biochem Pharmacol. 2009;77:1506-12.
32. Bae YS, Lee JH, Choi SH, Kim S, Almazan F, Witztum JL, Miller YI. Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ Res. 2009;104:210-8.